Catalog No.
YHE06901
Expression system
E. coli
Species
Homo sapiens (Human)
Protein length
Asp32-Tyr111
Predicted molecular weight
11.29 kDa
Nature
Recombinant
Endotoxin level
Please contact with the lab for this information.
Purity
>90% as determined by SDS-PAGE.
Accession
P35070
Applications
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Form
Lyophilized
Storage buffer
Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.
Reconstitution
Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.
Shipping
In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Alternative Names
Probetacellulin, BTC
PD-1/PD-L1 inhibitors plus chemotherapy versus chemotherapy alone as the first line treatment for advanced biliary tract cancer: a pooled analysis of KEYNOTE-966 and TOPAZ-1 trails., PMID:40495210
MOFs-Based Nanoinducer Enables Excessive Autophagy for Synergistic Photoimmunotherapy., PMID:40489118
Tebotelimab plus niraparib in previously treated locally advanced or metastatic solid tumors: A phase 1b dose escalation and expansion study., PMID:40445839
PD-L1 Expression in Biliary Tract Cancer: Comparison Across Antibody Clones and Role as a Predictor of Response to Chemoimmunotherapy: A Meta-Analysis., PMID:40440581
The IL-6/JAK/STAT3 Axis in Cholangiocarcinoma and Primary Sclerosing Cholangitis: Unlocking Therapeutic Strategies Through Patient-Derived Organoids., PMID:40426911
MDM2 as a therapeutic target in advanced biliary tract cancers., PMID:40421959
Efficacy and safety of combining tislelizumab with capecitabine compared to capecitabine alone in the adjuvant treatment of biliary tract cancers: rationale and protocol design for a randomized clinical trial., PMID:40414848
Generation of a biliary tract cancer cell line atlas identifies molecular subtypes and therapeutic targets., PMID:40353839
Real-world efficacy of zanidatamab in patients with HER2 positive advanced biliary tract cancers., PMID:40319675
Cost-effectiveness analysis of pembrolizumab plus chemotherapy as first-line treatment for advanced biliary tract cancer: perspectives from US and Chinese payers., PMID:40268484
New frontiers in the pharmacological management of biliary tract carcinomas: the emerging role of drug conjugates., PMID:40244683
Safety and Efficacy of Anti-Human Epidermal Growth Factor 2 Agents in the Treatment of Biliary Tract Cancers: A Systematic Review., PMID:40239136
Clinicomolecular Profile and Efficacy of Human Epidermal Growth Factor Receptor 2 (HER2)-Targeted Therapy for HER2-Amplified Advanced Biliary Tract Cancer., PMID:40209139
Comparison of monotherapy and combination therapy for older patients with advanced biliary tract cancer: a retrospective study., PMID:40205355
Mutations in ace2 gene modulate cytokine levels and alter immune responses in Mycobacterium tuberculosis and SARS-CoV-2 co-infection: a Cameroonian cohort., PMID:40196114
Plasma proteomic biomarkers predict therapeutic responses in advanced biliary tract cancer patients receiving Camrelizumab plus the GEMOX treatment., PMID:40195413
KIAA1199 (CEMIP) regulates adipogenesis and whole-body energy metabolism., PMID:40169533
Combined Chemotherapy-Immunotherapy for Advanced Biliary Tract Cancer (BTC): A Clinical, Genomic, and Biomarker Analysis., PMID:40167580
No Distinct Cytokine, Chemokine, and Growth Factor Blood Profile Associated With Monkeypox Virus Clade IIb Infected Patients., PMID:40156483
Health-related quality of life in participants with advanced biliary tract cancer from the randomized phase III KEYNOTE-966 study., PMID:40154623
Zanidatamab: First Approval., PMID:40108069
Analysis of the effectiveness and safety of lenvatinib/bevacizumab combined with PD-1/PD-L1 inhibitors and GEMOX in the first-line treatment of advanced biliary tract carcinoma., PMID:40106138
Comprehensive clinical and genetic characterization of hyperprogressive biliary tract cancer during PD-1 blockade monotherapy: case report and literature review., PMID:40087618
Metal ion of metal-organic frameworks facilitating immobilized chitinase performance., PMID:40081704
Diagnostic Performance of Radiolabelled FAPI Versus [18F]FDG PET Imaging in Hepato-Pancreato-Biliary Oncology: A Systematic Review and Meta-Analysis., PMID:40076605
Adrenomedullin Inhibits the Efficacy of Combined Immunotherapy and Targeted Therapy in Biliary Tract Cancer by Disrupting Endothelial Cell Functions., PMID:40074697
Respiratory burst oxidase G (SlRBOHG): A key regulator of H2O2-Mediated Na+ homeostasis and salt tolerance in tomato., PMID:40037174
Neurogenesis and glial impairments in congenital hydrocephalus: insights from a BioGlue-induced fetal lamb model., PMID:39994758
Serological and molecular analysis of henipavirus infections in synanthropic fruit bat and rodent populations in the Centre and North regions of Cameroon (2018-2020)., PMID:39994638
Accumulating Genetic Mutations from Primary to Secondary Biliary Tract Cancers: Analysis of Four Patients With Metachronous Biliary Tract Cancer Using Comprehensive Genomic Profiling., PMID:39993799
The association of endothelial nitric oxide synthase (eNOS) gene polymorphisms and diabetic retinopathy among patients with type 2 diabetes: A case-control study., PMID:39959179
Unique mechanisms to increase structural stability and enhance antigen binding in nanobodies., PMID:39938509
HER2-targeted therapies: Unraveling their role in biliary tract cancers., PMID:39923923
Collagen turnover biomarkers to predict outcome of patients with biliary cancer., PMID:39905306
Label-free electrochemical immunosensors based on Cu-Ni metal-organic framework and carbon nanotube composite for carcinoembryonic antigen detection., PMID:39883996
DNA damage response and repair gene mutations predict clinical outcomes in biliary tract cancer., PMID:39876053
IL-21 and IL-33 May Be Effective Biomarkers to Predict the Efficacy of PD-1 Monoclonal Antibody for Advanced Cholangiocarcinoma., PMID:39835991
The validation and clinical bioanalysis of the Bicycle® Toxin Conjugate zelenectide pevedotin in human plasma., PMID:39829185
Population pharmacokinetics and exposure-response analysis of durvalumab in combination with gemcitabine and cisplatin in patients with advanced biliary tract cancer., PMID:39821700
Molecular Profiling of Biliary Tract Cancers in African American and Caucasian Patients., PMID:39772832
The correlation between LAG-3 expression and the efficacy of chemoimmunotherapy in advanced biliary tract cancer., PMID:39751894
Comprehensive molecular characterization to predict immunotherapy response in advanced biliary tract cancer: a phase II trial of pembrolizumab., PMID:39735665
Screening of the effect of new food prototypes based on fermented lentil and quinoa flours on the colonic microbiota of older adults through a static in vitro colonic fermentation model., PMID:39703012
BilT03: Phase 1b/2 multicenter trial of nivolumab with 5-fluorouracil and liposomal irinotecan for previously treated advanced biliary tract cancer., PMID:39701097
A novel strategy of dysphagia-oriented matrices bovine tendon collagen-cassava starch composite gels., PMID:39672436
SWOG S1815: A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers., PMID:39671534
The Cdk inhibitor dinaciclib as a promising anti-tumorigenic agent in biliary tract cancer., PMID:39668430
Clinical and biomarker analyses of SHR-1701 combined with famitinib in patients with previously treated advanced biliary tract cancer or pancreatic ductal adenocarcinoma: a phase II trial., PMID:39668159
The imprinted Igf2-Igf2r axis is critical for exosome biogenesis during the early development of bovine placenta., PMID:39662929
First-line systemic therapy and sequencing options in advanced biliary tract cancer: A systematic review and network meta-analysis., PMID:39647857
For research use only. Not for human or drug use.
